| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | BDPLT2,CD41 antigen, CD41a, gp2b, ITGA2B, platelet fibrinogen receptor alpha |
| Clonality | |
| Concentration | |
| Gene ID | |
| Host | |
| Immunogen | Synthetic Peptide |
| Isotype | |
| Product Type | |
| Reactivity | |
| Storage |
Product Overview
Polyclonal Primary AntibodyAnti-CD41/Integrin α/2b Mouse mAb antibody (, -derived) validated for use in multiple research applications. Targets CD41/Integrin α/2b Mouse mAb in validated species samples.
Antibody Specifications
Scientific Background
ITGA2B encodes integrin alpha chain 2b. Integrins are heterodimeric integral membrane proteins composed of an alpha chain and a beta chain. Alpha chain 2b undergoes post-translational cleavage to yield disulfide-linked light and heavy chains that join with beta 3 to form a fibrinogen receptor expressed in platelets that plays a crucial role in coagulation.
Subcellular Location: Membrane
Safety & Handling
Related Products
Explore our complete catalog of antibodies, ELISA kits, and life science research reagents at BioHippo.
Store at -20°C for long-term storage. For short-term use (up to 4 weeks), store at 4°C. Avoid repeated freeze-thaw cycles. Centrifuge briefly before opening if condensation is visible.
Customization & Add-ons: Can’t find the antibody you need—or require a custom format for your assay? We can help you source the best match or support custom antibody solutions for diverse research needs, including species and isotype selection, conjugations and labeling (e.g., HRP/AP, biotin, fluorophores), purification grade options (Protein A/G, affinity purified), formulation preferences (buffer selection, carrier-free, glycerol-free), custom concentrations and aliquoting, low-endotoxin options for cell-based work, and application-focused QC/validation support (project dependent). Click Talk to a Scientist to submit a request, email us at support@biohippo.com, or explore our Research Services for additional support—our team will follow up with feasibility details and next steps.